Unknown PHASE2 INTERVENTIONAL NCT00327314

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Sponsor: Azienda Ospedaliera San Giovanni Battista

Interventions Hematopoietic cell transplantation Transplantation

Updated 5 times since 2017 Last updated: Dec 27, 2006 Started: Dec 31, 2002 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00327314, this PHASE2 trial focuses on Multiple Myeloma and remains ongoing. Sponsored by Azienda Ospedaliera San Giovanni Battista, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera San Giovanni Battista

Data source: Azienda Ospedaliera San Giovanni Battista

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Torino, Italy